Suppr超能文献

经肛门内镜微创手术治疗直肠良恶性肿瘤后的复发:新西兰单一中心的经验。

Recurrence after transanal endoscopic microsurgery for benign and malignant rectal tumours: experience of a single New Zealand centre.

机构信息

Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

出版信息

ANZ J Surg. 2024 Mar;94(3):412-417. doi: 10.1111/ans.18780. Epub 2023 Nov 14.

Abstract

BACKGROUND

Transanal endoscopic microsurgery (TEM) is an established technique for the resection of rectal adenomas and selected malignant tumours. It avoids the morbidity of radical resection for tumours not amenable to endoscopic resection. An important marker of quality is the local recurrence rate. The primary objective was to determine local recurrence rates for benign and malignant rectal tumours.

METHODS

We identified index TEM excisions of rectal adenomas and adenocarcinomas in patients age 18 and over at Dunedin Hospital, New Zealand, between 2000 and 2020, from a prospective database. Surveillance data were collected via chart review. The primary outcome was recurrence rate for adenomas and adenocarcinomas. Secondary outcomes included time to recurrence, association of recurrence with recognized risk factors, and adverse event rates.

RESULTS

We identified 100 patients for analysis. Of 75 benign cases, 11 (14.7%) developed local recurrence, with 63.6% identified within 1 year. Of the 25 malignant cases (19 T1, 5 T2, 1 T3), 9 (36%) developed recurrence, with 77.8% identified within 2 years. Adverse events occurred in 26% of patients, with no reoperations or deaths.

CONCLUSION

Our adenoma recurrence rate was at the higher end of the reported range of 2.4-16%. Minor complications were common, but not major morbidity. The propensity for rectal tumours to recur commonly and early reinforces the importance of regular standardized endoscopic surveillance.

摘要

背景

经肛门内镜微创手术(TEM)是一种成熟的技术,用于切除直肠腺瘤和某些恶性肿瘤。它避免了因不能进行内镜切除而对肿瘤进行根治性切除的发病率。一个重要的质量指标是局部复发率。主要目的是确定良性和恶性直肠肿瘤的局部复发率。

方法

我们从新西兰达尼丁医院的一个前瞻性数据库中确定了 2000 年至 2020 年间年龄在 18 岁及以上的患者的直肠腺瘤和腺癌的 TEM 索引切除术。通过图表审查收集监测数据。主要结局是腺瘤和腺癌的复发率。次要结局包括复发时间、复发与公认的危险因素的关系以及不良事件发生率。

结果

我们确定了 100 名患者进行分析。75 例良性病例中,11 例(14.7%)发生局部复发,其中 63.6%在 1 年内发现。25 例恶性病例(19 例 T1、5 例 T2、1 例 T3)中,9 例(36%)发生复发,其中 77.8%在 2 年内发现。26%的患者发生不良事件,但无再次手术或死亡。

结论

我们的腺瘤复发率处于报告的 2.4-16%范围内的较高端。轻微并发症很常见,但无重大发病率。直肠肿瘤普遍且早期复发的倾向强调了定期进行标准化内镜监测的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验